Community-acquired pneumonia: Difference between revisions
No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
'''For the main page on pneumonia, click [[pneumonia|here]]''' | '''For the main page on pneumonia, click [[pneumonia|here]]''' | ||
'''For patient information on pneumonia, click [[Pneumonia (patient information)|here]] | |||
'''Editor(s)-in-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto:charlesmichaelgibson@gmail.com] Phone:617-632-7753; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.D.]] [mailto:psingh13579@gmail.com] | '''Editor(s)-in-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto:charlesmichaelgibson@gmail.com] Phone:617-632-7753; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.D.]] [mailto:psingh13579@gmail.com] |
Revision as of 19:49, 27 February 2013
Pneumonia | |
![]() |
---|
Community-Acquired Pneumonia Microchapters |
Differentiating Community-acquired pneumonia from other Diseases |
Diagnosis |
Treatment |
Case Studies |
Community-acquired pneumonia On the Web |
American Roentgen Ray Society Images of Community-acquired pneumonia |
Directions to Hospitals Treating Community-acquired pneumonia |
Risk calculators and risk factors for Community-acquired pneumonia |
For the main page on pneumonia, click here
For patient information on pneumonia, click here
Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Associate Editor(s)-In-Chief: Priyamvada Singh, M.D. [2]
Synonyms and keywords: CAP
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Community-acquired pneumonia from other Diseases
Epidemiology and Demographics
Risk factors
Natural History, Complications and Prognosis
Diagnosis
Criteria for Severe Community-acquired Pneumonia | CURB-65 Clinical Prediction Rule | Community-acquired Pneumonia Severity Index | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies